Aorta Aneurysm
Conditions
Keywords
Stents, Thrombosis
Brief summary
The purpose of this study is to assess the extent of thrombosis in the Zenith Alpha Spiral-Z® stent graft.
Detailed description
Cook Medical has reported thrombus formation with or without occlusion of the Zenith Alpha Spiral-Z®. The purpose of this study is to measure the extent of thrombus formation and occlusion of these stent graft limbs in patients with aortic aneurysms treated at St. Olavs Hospital in 2017, 2018 and 2019. Information is collected from the Norwegian registry for vascular surgery (NORKAR), electronic patient journal and the picture archiving and communication system (PACS). The total number of included patients is estimated to be approximately 100.
Interventions
The Zenith Alpha Spiral-Z® stent graft may have an increased risk of thrombosis. The intervention in this study is to assess the extent and degree of thrombosis in patients treated with the Zenith Alpha Spiral-Z® during endovascular repair of aortic aneurysm
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients that have received endovascular treatment with the Zenith Alpha Spiral-Z® for an aortic aneurysm * The endovascular procedure was performed at St Olavs Hospital from January 2017 until December 2019
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patients who have got treated post-surgery due to thrombosis or occlusion of stent graft leg | 12-36 months | Any endovascular or surgical procedure to treat thrombosis or occlusion |
| Percentage of patients who got an amputation post-surgery due to thrombosis or occlusion of stent graft leg | 12-36 months | Any amputation in the affected limb / same side as thrombosed stent graft leg |
| Percentage of patients who died post-surgery | 12-36 months | Death of any cause during the observation time |
Countries
Norway